Disc Medicine (IRON) Research & Development (2020 - 2026)

Disc Medicine (IRON) has 7 years of Research & Development data on file, last reported at $45.9 million in Q1 2026.

• Research & Development for Q1 2026 came in at $45.9 million, up 65.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $188.8 million (up 87.41% YoY), and the FY2025 annual result was $170.6 million, up 76.52% from the prior year.
• Research & Development eased to $45.9 million in Q1 2026 per IRON's latest filing, from $46.2 million in the prior quarter.
• Over five years, Research & Development peaked at $50.3 million in Q3 2025 and troughed at $7.7 million in Q2 2022.
• A 5-year average of $24.5 million and a median of $23.5 million in 2024 frame the typical range for Research & Development.
• On a YoY basis, Research & Development climbed as much as 191.78% in 2022 and fell as far as 41.39% in 2022.
• A 5-year view of Research & Development shows it stood at $10.0 million in 2022, then surged by 125.29% to $22.6 million in 2023, then advanced by 9.89% to $24.8 million in 2024, then jumped by 86.41% to $46.2 million in 2025, then dropped by 0.69% to $45.9 million in 2026.
• Business Quant data shows IRON's Research & Development at $45.9 million in Q1 2026, $46.2 million in Q4 2025, and $50.3 million in Q3 2025.